U.S.A. FDA warns: Five sections of rheumatism medicine is very carcinogenic There is production at home

U.S.A. FDA warns: Five sections of rheumatism medicine is very carcinogenic There is production at home
Include the necrosis factor inhibitor composition of tumour May cause children to suffer from lymphoma Domestic producer: Have already joined relevantly in medicines have explained and warned
It is reported ' Reporter cub reporter Yang Zheng and Lin ChenYin) Contain " necrosis factor of tumour (TNF) Inhibitor " Arthritis specific drug of the composition may increase children and teenagers and suffer from the risk of cancer.


American food medicines supervise the administration bureau (FDA) Claimed yesterday, FDA had already sent out the instruction to pharmacy enterprises, had required it to add relevant important warning into operation instructions.
FDA claims, this kind of medicine can be with destroying osseous TNF protein to combine in the joint, play a role in inhibiting to it. Besides rheumatic arthritis, are also used for treating Crohn's disease (a kind of intestinal inflammation) , ulcer enteritis,etc. and disease. Because the drug effect is prominent, they have already become the American most popular therapeutic medicine (name is seen the list) of rheumatism .
FDA investigation finds, in children and teenagers who uses TNF inhibitor, 48 people suffer from cancers such as lymphoma,etc., the risk of suffering from cancer after using 2 and a half years will rise.
FDA began to survey side effect of TNF inhibitor since last June. An analysis report claims, children and teenagers are after accepting TNF inhibitor treatment 30 months the probability which suffer from cancer will increase. Among them, about half the a case is lymphoma.
Medicine name Another name Applicable disease
Favourable Xidan, of Great Britain, resists Each Rheumatoid and arthritis, strong straightforward backbone inflammation depend on the west generally Former times of Great Britain's profit It is it low to endanger /in endanger bone marrow hyperplasia syndrome As unusual reach forms wooden resist at Humira to rheumatoid arthritis Cimzia (have at home)s severe -Rheumatic arthritis Simponi ( Do not have at home) -Rheumatic arthritis
Visit the producer
Have already joined relevantly to warn that have a match generally in accordance with the general domestic benefit by name in the west in medicines have explained, strong in Pharmaceutcal Co., Ltd. to research and develop and was listed by Shanghai CITIC country in 2005. Lady expresses the brightness of Hunan of the leaf of public relation manager of this company when being interviewed by reporter in the morning, the company has already understood the side effect of medicines, though has not seen the latest instruction of FDA yet at present, but put into relevantly warning in the medicines that benefit is general in match explained.
The brightness of Hunan of the leaf introduces, it is a new kind of medicines curing rheumatic arthritis that benefit has a match generally, as to in the past apt to cause first the intersection of ammonia and the intersection of butterfly and the intersection of purine,etc. and similar medicines of leukemia, its side effect is minimum at present. Abroad, treat infant's rheumatic arthritis and mostly use this kind of medicines, at home, because the listing time of this medicines is not long, and the price is more expensive (use one month to need to cost 7,000 to 8,000 yuan) ,The patient using it is not numerous yet.
She says, FDA investigations finds that there are 30 that use " necrosis factor of tumour (TNF) Inhibitor " Children suffer from by cancer,2 to 3 times higher than situations general in proportion, but caused by these medicines in final conclusion at that timing. Document cub reporter Lin ChenYin
The expert understands
When the regular medicine is invalid Consider using again
This morning, immune department's king shook colleague's rheumatism of the hospital just a director told reporters, five in the medicine that FDA warn, in accordance with general to realize production domesticization the west that, use at clinic to some extent at present. Because these medicines belong to the artificial biologic product, is included abroad in the medical insurance category, so the foreign patient can use for a long time.
Director Wang ZhenGang says, these medicines still belong to medicine at one's own expense at home, in order to depend on the west generally as the example, one is about 450 yuan, need to use for four times per week, it is about 2000 yuan altogether, short-term course of treatment is about three to four weeks, this is ordinary person's price very difficult to afford. So, face the use in bed at present and tell they may know under the prerequisite which present tumour, use this kind of medicine in a short time for a fixed period of time. "Though there are certain risks, can relieve the patient's illness effectively. " Director Wang says, generally all will consider using this kind of medicine when the regular medicine is unable to control the condition, and will depend on the patient's economic ability.With the enhancement of health consciousness, people pay more and more attention to with the life closely bound up health problem, such as the food security, medical treatment is ensured, medical information,etc., healthy life should be from understanding information begins!More excellent health information please enter:News channel
|